|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 313 for Cd274

Category restricted to Publication (x)

0.055s

Categories

Category: Publication
Type Details Score
Publication
First Author: Ni X
Year: 2017
Journal: J Clin Invest
Title: PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells.
Volume: 127
Issue: 5
Pages: 1960-1977
Publication
First Author: Hams E
Year: 2011
Journal: J Immunol
Title: Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.
Volume: 186
Issue: 10
Pages: 5648-55
Publication
First Author: Neumann K
Year: 2019
Journal: Sci Rep
Title: The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis.
Volume: 9
Issue: 1
Pages: 2038
Publication
First Author: Akbari O
Year: 2010
Journal: Mucosal Immunol
Title: PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.
Volume: 3
Issue: 1
Pages: 81-91
Publication
First Author: Maazi H
Year: 2013
Journal: PLoS One
Title: Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection.
Volume: 8
Issue: 3
Pages: e59599
Publication
First Author: Liang SC
Year: 2006
Journal: Eur J Immunol
Title: PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis.
Volume: 36
Issue: 1
Pages: 58-64
Publication
First Author: Akhmetzyanova I
Year: 2015
Journal: PLoS Pathog
Title: PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing.
Volume: 11
Issue: 10
Pages: e1005224
Publication
First Author: Schreiner B
Year: 2008
Journal: Eur J Immunol
Title: PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.
Volume: 38
Issue: 10
Pages: 2706-17
Publication
First Author: Barber DL
Year: 2011
Journal: J Immunol
Title: CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition.
Volume: 186
Issue: 3
Pages: 1598-607
Publication
First Author: Keir ME
Year: 2006
Journal: J Exp Med
Title: Tissue expression of PD-L1 mediates peripheral T cell tolerance.
Volume: 203
Issue: 4
Pages: 883-95
Publication
First Author: Pauken KE
Year: 2020
Journal: Cell Rep
Title: The PD-1 Pathway Regulates Development and Function of Memory CD8+ T Cells following Respiratory Viral Infection.
Volume: 31
Issue: 13
Pages: 107827
Publication
First Author: Keir ME
Year: 2005
Journal: J Immunol
Title: Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.
Volume: 175
Issue: 11
Pages: 7372-9
Publication
First Author: Charles E
Year: 2010
Journal: Infect Immun
Title: CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1.
Volume: 78
Issue: 8
Pages: 3484-92
Publication
First Author: Ding Q
Year: 2006
Journal: J Immunol
Title: B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells.
Volume: 177
Issue: 6
Pages: 3606-14
Publication
First Author: Xiao K
Year: 2024
Journal: Cell Rep
Title: PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy.
Volume: 43
Issue: 11
Pages: 114868
Publication
First Author: Paterson AM
Year: 2011
Journal: J Immunol
Title: The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Volume: 187
Issue: 3
Pages: 1097-105
Publication
First Author: Li R
Year: 2015
Journal: Diabetes
Title: PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.
Volume: 64
Issue: 2
Pages: 529-40
Publication
First Author: Wang GZ
Year: 2019
Journal: Nat Commun
Title: The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy.
Volume: 10
Issue: 1
Pages: 1125
Publication
First Author: Lucas JA
Year: 2008
Journal: J Immunol
Title: Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
Volume: 181
Issue: 4
Pages: 2513-21
Publication
First Author: Sumpter TL
Year: 2012
Journal: J Immunol
Title: Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO.
Volume: 189
Issue: 8
Pages: 3848-58
Publication
First Author: Fankhauser SC
Year: 2014
Journal: J Immunol
Title: PD-L1 limits the mucosal CD8+ T cell response to Chlamydia trachomatis.
Volume: 192
Issue: 3
Pages: 1079-90
Publication
First Author: Lin H
Year: 2018
Journal: J Clin Invest
Title: Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.
Volume: 128
Issue: 2
Pages: 805-815
Publication
First Author: Furusawa E
Year: 2019
Journal: J Invest Dermatol
Title: Silencing of PD-L2/B7-DC by Topical Application of Small Interfering RNA Inhibits Elicitation of Contact Hypersensitivity.
Volume: 139
Issue: 10
Pages: 2164-2173.e1
Publication
First Author: Moreira TG
Year: 2021
Journal: Nat Commun
Title: PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis.
Volume: 12
Issue: 1
Pages: 4907
Publication
First Author: Francisco LM
Year: 2009
Journal: J Exp Med
Title: PD-L1 regulates the development, maintenance, and function of induced regulatory T cells.
Volume: 206
Issue: 13
Pages: 3015-29
Publication  
First Author: Scheurer J
Year: 2021
Journal: Front Immunol
Title: Graft-Versus-Host Disease Prevention by In Vitro-Generated Myeloid-Derived Suppressor Cells Is Exclusively Mediated by the CD11b+CD11c+ MDSC Subpopulation.
Volume: 12
Pages: 754316
Publication
First Author: Jaworska K
Year: 2015
Journal: J Immunol
Title: Both PD-1 ligands protect the kidney from ischemia reperfusion injury.
Volume: 194
Issue: 1
Pages: 325-33
Publication
First Author: Ruf B
Year: 2023
Journal: Cell
Title: Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.
Volume: 186
Issue: 17
Pages: 3686-3705.e32
Publication  
First Author: Kleczko EK
Year: 2023
Journal: JCI Insight
Title: Immune checkpoint activity regulates polycystic kidney disease progression.
Volume: 8
Issue: 12
Publication
First Author: Liu J
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
Volume: 112
Issue: 21
Pages: 6682-7
Publication
First Author: Bu DX
Year: 2011
Journal: Arterioscler Thromb Vasc Biol
Title: Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
Volume: 31
Issue: 5
Pages: 1100-7
Publication
First Author: Yao S
Year: 2009
Journal: Blood
Title: PD-1 on dendritic cells impedes innate immunity against bacterial infection.
Volume: 113
Issue: 23
Pages: 5811-8
Publication
First Author: Kang S
Year: 2017
Journal: Mucosal Immunol
Title: Unique B7-H1 expression on masticatory mucosae in the oral cavity and trans-coinhibition by B7-H1-expressing keratinocytes regulating CD4+ T cell-mediated mucosal tissue inflammation.
Volume: 10
Issue: 3
Pages: 650-660
Publication
First Author: Matta BM
Year: 2012
Journal: J Immunol
Title: IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells.
Volume: 188
Issue: 11
Pages: 5227-37
Publication
First Author: Yi T
Year: 2009
Journal: Blood
Title: Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
Volume: 114
Issue: 14
Pages: 3101-12
Publication
First Author: Ruffner MA
Year: 2009
Journal: Eur J Immunol
Title: B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.
Volume: 39
Issue: 11
Pages: 3084-90
Publication
First Author: Chopy D
Year: 2011
Journal: J Virol
Title: Ambivalent role of the innate immune response in rabies virus pathogenesis.
Volume: 85
Issue: 13
Pages: 6657-68
Publication
First Author: Butler NS
Year: 2011
Journal: Nat Immunol
Title: Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection.
Volume: 13
Issue: 2
Pages: 188-95
Publication
First Author: Spranger S
Year: 2013
Journal: Sci Transl Med
Title: Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
Volume: 5
Issue: 200
Pages: 200ra116
Publication
First Author: Schneider MA
Year: 2021
Journal: Sci Transl Med
Title: Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models.
Volume: 13
Issue: 611
Pages: eabc8188
Publication
First Author: McKay JT
Year: 2017
Journal: J Immunol
Title: PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.
Volume: 199
Issue: 6
Pages: 2020-2029
Publication
First Author: Eichel MA
Year: 2020
Journal: Nat Commun
Title: CMTM6 expressed on the adaxonal Schwann cell surface restricts axonal diameters in peripheral nerves.
Volume: 11
Issue: 1
Pages: 4514
Publication
First Author: Grabie N
Year: 2007
Journal: Circulation
Title: Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart.
Volume: 116
Issue: 18
Pages: 2062-71
Publication  
First Author: Petty AJ
Year: 2021
Journal: JCI Insight
Title: Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function.
Volume: 6
Issue: 6
Publication  
First Author: Khan AR
Year: 2015
Journal: Nat Commun
Title: PD-L1hi B cells are critical regulators of humoral immunity.
Volume: 6
Pages: 5997
Publication
First Author: Batista A
Year: 2020
Journal: PLoS Biol
Title: IRE1α regulates macrophage polarization, PD-L1 expression, and tumor survival.
Volume: 18
Issue: 6
Pages: e3000687
Publication
First Author: Phares TW
Year: 2009
Journal: J Immunol
Title: Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.
Volume: 182
Issue: 9
Pages: 5430-8
Publication
First Author: Schuster C
Year: 2013
Journal: PLoS One
Title: A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.
Volume: 8
Issue: 8
Pages: e71746
Publication
First Author: Pauken KE
Year: 2013
Journal: Diabetes
Title: PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
Volume: 62
Issue: 8
Pages: 2859-69
Publication
First Author: McKay JT
Year: 2015
Journal: J Immunol
Title: PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism.
Volume: 194
Issue: 5
Pages: 2289-99
Publication
First Author: Karunarathne DS
Year: 2016
Journal: Immunity
Title: Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.
Volume: 45
Issue: 2
Pages: 333-45
Publication
First Author: Saha A
Year: 2016
Journal: J Clin Invest
Title: Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.
Volume: 126
Issue: 7
Pages: 2642-60
Publication
First Author: Baban B
Year: 2011
Journal: J Immunol
Title: Physiologic control of IDO competence in splenic dendritic cells.
Volume: 187
Issue: 5
Pages: 2329-35
Publication
First Author: Goding SR
Year: 2018
Journal: J Immunol
Title: PD-L1-Independent Mechanisms Control the Resistance of Melanoma to CD4+ T Cell Adoptive Immunotherapy.
Volume: 200
Issue: 9
Pages: 3304-3311
Publication
First Author: Gotsman I
Year: 2007
Journal: J Clin Invest
Title: Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.
Volume: 117
Issue: 10
Pages: 2974-82
Publication  
First Author: Gu X
Year: 2013
Journal: Clin Dev Immunol
Title: Interferon- γ triggers hepatic stellate cell-mediated immune regulation through MEK/ERK signaling pathway.
Volume: 2013
Pages: 389807
Publication
First Author: Li Y
Year: 2015
Journal: J Immunol
Title: Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.
Volume: 195
Issue: 6
Pages: 2648-56
Publication
First Author: Lin PY
Year: 2010
Journal: J Immunol
Title: B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses.
Volume: 185
Issue: 5
Pages: 2747-53
Publication
First Author: Wood MK
Year: 2024
Journal: Arthritis Rheumatol
Title: Programmed Death Ligand 1-Expressing Macrophages and Their Protective Role in the Joint During Arthritis.
Volume: 76
Issue: 4
Pages: 553-565
Publication
First Author: Butte MJ
Year: 2007
Journal: Immunity
Title: Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
Volume: 27
Issue: 1
Pages: 111-22
Publication
First Author: Highfill SL
Year: 2014
Journal: Sci Transl Med
Title: Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.
Volume: 6
Issue: 237
Pages: 237ra67
Publication
First Author: Elhofy A
Year: 2009
Journal: J Neuroimmunol
Title: Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis.
Volume: 213
Issue: 1-2
Pages: 91-9
Publication
First Author: Liu JL
Year: 2021
Journal: Cell Mol Gastroenterol Hepatol
Title: Circadian Clock Disruption Suppresses PDL1+ Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer.
Volume: 12
Issue: 1
Pages: 251-276
Publication
First Author: Cao Y
Year: 2011
Journal: Cancer Res
Title: B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin.
Volume: 71
Issue: 4
Pages: 1235-43
Publication
First Author: Zhang L
Year: 2009
Journal: Blood
Title: PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model.
Volume: 114
Issue: 8
Pages: 1545-52
Publication
First Author: Erickson JJ
Year: 2012
Journal: J Clin Invest
Title: Viral acute lower respiratory infections impair CD8+ T cells through PD-1.
Volume: 122
Issue: 8
Pages: 2967-82
Publication
First Author: Sakai S
Year: 2010
Journal: Int Immunol
Title: PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin.
Volume: 22
Issue: 12
Pages: 915-25
Publication
First Author: Nakajima M
Year: 2021
Journal: Sci Rep
Title: Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium.
Volume: 11
Issue: 1
Pages: 18008
Publication
First Author: Azuma T
Year: 2008
Journal: Blood
Title: B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells.
Volume: 111
Issue: 7
Pages: 3635-43
Publication
First Author: Wang L
Year: 2007
Journal: Eur J Immunol
Title: Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
Volume: 37
Issue: 10
Pages: 2983-90
Publication
First Author: Sugita S
Year: 2013
Journal: Invest Ophthalmol Vis Sci
Title: Suppression of IL-22-producing T helper 22 cells by RPE cells via PD-L1/PD-1 interactions.
Volume: 54
Issue: 10
Pages: 6926-33
Publication
First Author: Huffaker TB
Year: 2017
Journal: J Biol Chem
Title: Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade.
Volume: 292
Issue: 45
Pages: 18530-18541
Publication
First Author: Martin-Orozco N
Year: 2006
Journal: J Immunol
Title: Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
Volume: 177
Issue: 12
Pages: 8291-5
Publication
First Author: Chen G
Year: 2018
Journal: Nature
Title: Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
Volume: 560
Issue: 7718
Pages: 382-386
Publication
First Author: Chen G
Year: 2017
Journal: Nat Neurosci
Title: PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1.
Volume: 20
Issue: 7
Pages: 917-926
Publication
First Author: Tober J
Year: 2018
Journal: J Exp Med
Title: Maturation of hematopoietic stem cells from prehematopoietic stem cells is accompanied by up-regulation of PD-L1.
Volume: 215
Issue: 2
Pages: 645-659
Publication
First Author: Augello A
Year: 2005
Journal: Eur J Immunol
Title: Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.
Volume: 35
Issue: 5
Pages: 1482-90
Publication
First Author: Fife BT
Year: 2006
Journal: J Exp Med
Title: Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.
Volume: 203
Issue: 12
Pages: 2737-47
Publication
First Author: He FR
Year: 2008
Journal: Clin Exp Immunol
Title: Programmed death-1 ligands-transfected dendritic cells loaded with glutamic acid decarboxylase 65 (GAD65) inhibit both the alloresponse and the GAD65-reactive lymphocyte response.
Volume: 151
Issue: 1
Pages: 86-93
Publication
First Author: Chang WS
Year: 2008
Journal: J Immunol
Title: Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.
Volume: 181
Issue: 10
Pages: 6707-10
Publication
First Author: Reynoso ED
Year: 2009
Journal: J Immunol
Title: Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.
Volume: 182
Issue: 4
Pages: 2102-12
Publication
First Author: Currie AJ
Year: 2009
Journal: J Immunol
Title: Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
Volume: 183
Issue: 12
Pages: 7898-908
Publication
First Author: Fife BT
Year: 2009
Journal: Nat Immunol
Title: Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
Volume: 10
Issue: 11
Pages: 1185-92
Publication
First Author: Frank GM
Year: 2010
Journal: J Immunol
Title: Early CD4(+) T cell help prevents partial CD8(+) T cell exhaustion and promotes maintenance of Herpes Simplex Virus 1 latency.
Volume: 184
Issue: 1
Pages: 277-86
Publication
First Author: Hailemichael Y
Year: 2018
Journal: J Clin Invest
Title: Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy.
Volume: 128
Issue: 4
Pages: 1338-1354
Publication
First Author: Zhou J
Year: 2019
Journal: Immunity
Title: Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis.
Volume: 50
Issue: 2
Pages: 403-417.e4
Publication
First Author: Narayanapillai SC
Year: 2020
Journal: Carcinogenesis
Title: Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis.
Volume: 41
Issue: 11
Pages: 1518-1528
Publication
First Author: Herold M
Year: 2015
Journal: J Immunol
Title: B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Volume: 195
Issue: 8
Pages: 3584-95
Publication
First Author: Wang J
Year: 2017
Journal: Cancer Prev Res (Phila)
Title: PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Volume: 10
Issue: 12
Pages: 684-693
Publication
First Author: Wang TW
Year: 2022
Journal: Nature
Title: Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes.
Volume: 611
Issue: 7935
Pages: 358-364
Publication
First Author: Good-Jacobson KL
Year: 2010
Journal: Nat Immunol
Title: PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.
Volume: 11
Issue: 6
Pages: 535-42
Publication
First Author: Carter LL
Year: 2007
Journal: J Neuroimmunol
Title: PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.
Volume: 182
Issue: 1-2
Pages: 124-34
Publication
First Author: Juneja VR
Year: 2017
Journal: J Exp Med
Title: PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.
Volume: 214
Issue: 4
Pages: 895-904
Publication
First Author: Hirano T
Year: 2021
Journal: J Allergy Clin Immunol
Title: PD-L1 on mast cells suppresses effector CD8(+) T-cell activation in the skin in murine contact hypersensitivity.
Volume: 148
Issue: 2
Pages: 563-573.e7
Publication
First Author: Klotz L
Year: 2009
Journal: J Immunol
Title: Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
Volume: 183
Issue: 1
Pages: 129-36
Publication
First Author: Yang J
Year: 2008
Journal: Circulation
Title: Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
Volume: 117
Issue: 5
Pages: 660-9
Publication
First Author: Juchem KW
Year: 2018
Journal: J Immunol
Title: PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.
Volume: 200
Issue: 2
Pages: 834-846
Publication
First Author: Ogishi M
Year: 2024
Journal: Immunity
Title: Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling.
Volume: 57
Issue: 12
Pages: 2790-2807.e15
Publication
First Author: Sage PT
Year: 2018
Journal: J Immunol
Title: Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function.
Volume: 200
Issue: 8
Pages: 2592-2602
Publication
First Author: Mascanfroni ID
Year: 2013
Journal: Nat Immunol
Title: IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.
Volume: 14
Issue: 10
Pages: 1054-63